Jichuan Pharmaceutical: “Jichuan Convertible Bonds” converted 3,110 shares in the first quarter, and a total of about 5.32 million shares were converted_Oriental Fortune Network

　　Jecheon Pharmaceutical(SH 600566, closing price: 25.71 yuan) Released on the evening of April 1announcementIt is stated that from January 1, 2022 to March 31, 2022 (this change), a total of about 73,000 yuan of “Jichuan convertible bonds” were converted into company stocks,Convert stockThe number is 3110 shares, accounting forconvertible bonds0.000384% of the total issued shares of the company before the conversion. As of March 31, 2022, a total of about 213 million yuan of “Jichuan Convertible Bonds” have been converted into company shares, and the number of shares converted is about 5.3223 million shares, accounting for 0.66% of the company’s total issued shares before the convertible bond conversion. As of March 31, 2022, the amount of convertible bonds that have not been converted into shares was about 630 million yuan, accounting for 74.76% of the total amount of convertible bonds issued.

From January to December 2020,Jecheon PharmaceuticalofOperating incomeThe composition is: heat-clearing and detoxifying category accounts for 34.72%, digestive category accounts for 27.41%, pediatric category accounts for 16.84%, other industries account for 10.43%, and respiratory category accounts for 4.54%.

　　Jecheon PharmaceuticalThe chairman of the board is Cao Longxiang, male, 65 years old, with a master’s degree.

(Article source: Daily Economic News)

Article source: Daily Economic News

Responsible editor: 92

Original title: Jichuan Pharmaceutical: “Jichuan Convertible Bonds” converted 3,110 shares in the first quarter, with a total of about 5.32 million shares converted